Changes in LCI in F508del/F508del patients treated with lumacaftor/ivacaftor: Results from the prospect study
Michelle Shaw, Umer Khan, John Clancy, Scott H. Donaldson, Scott D. Sagel, Steven M. Rowe, Félix Ratjen
Topics & Concepts
IvacaftorMedicineSpirometryLung functionObservational studyCystic fibrosisInternal medicinePopulationLungCystic fibrosis transmembrane conductance regulatorAsthmaEnvironmental healthCystic Fibrosis Research AdvancesAsthma and respiratory diseasesTracheal and airway disorders